Insider · CIK 0001013420

GRONINGER JAMES G

Reports to the SEC for 2 companies · BEDMINSTER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001013420

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-02-21	NPS PHARMACEUTICALS INCDeferred Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−121K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCU Disposition from Tender	Director	UDisposition from Tender	−9,188 sh	$46.00	−$423K	0
2015-02-21	NPS PHARMACEUTICALS INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,816 sh	—	—	0
2015-02-12	NPS PHARMACEUTICALS INCRestricted Stock UnitsA Award	Director	AAward	+3,816 sh	—	—	3,816
2014-02-13	NPS PHARMACEUTICALS INCS Sale	Director	SSale	−6,000 sh	$37.70	−$226K	9,938
2014-02-13	NPS PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.2K sh	—	—	0
2014-02-13	NPS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+15.2K sh	—	—	15,938
2014-02-12	NPS PHARMACEUTICALS INCRestricted Stock UnitsA Award	Director	AAward	+4,572 sh	—	—	4,572
2013-12-23	NPS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$21.73	+$65.2K	3,750
2013-12-23	NPS PHARMACEUTICALS INCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	0
2013-12-23	NPS PHARMACEUTICALS INCS Sale	Director	SSale	−3,000 sh	$29.50	−$88.5K	750
2013-08-20	NPS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.24	+$42.4K	20,650
2013-08-20	NPS PHARMACEUTICALS INCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	26,000
2013-08-20	NPS PHARMACEUTICALS INCG Gift	Director	GGift	−3,000 sh	—	—	750
2013-08-20	NPS PHARMACEUTICALS INCS Sale	Director	SSale	−16.9K sh	$23.21	−$392K	3,750
2013-02-13	NPS PHARMACEUTICALS INCRestricted Stock UnitsA Award	Director	AAward	+15.2K sh	—	—	15,188
2013-02-07	NPS PHARMACEUTICALS INCS Sale	Director	SSale	−5,325 sh	$8.74	−$46.5K	10,650
2013-02-07	NPS PHARMACEUTICALS INCJ Other	Director	JOther	+15.2K sh	—	—	15,975
2012-02-07	NPS PHARMACEUTICALS INCA Award	Director	AAward	+15.2K sh	—	—	15,225
2012-01-17	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,278 sh	—	—	121,039
2011-10-17	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,258 sh	—	—	118,761
2011-07-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+1,577 sh	—	—	116,503
2011-05-19	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+1,508 sh	—	—	114,926
2011-04-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+1,691 sh	—	—	113,418
2011-01-18	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+1,899 sh	—	—	111,727
2010-10-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,271 sh	—	—	109,828
2010-07-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,500 sh	—	—	107,557
2010-05-20	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,333 sh	—	—	105,057
2010-04-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,512 sh	—	—	102,724
2009-10-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+4,609 sh	—	—	100,212
2009-10-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+4,189 sh	—	—	95,603
2009-09-23	NPS PHARMACEUTICALS INCStock OptionsA Award	Director	AAward	+36K sh	—	—	36,000
2009-07-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+3,094 sh	—	—	91,414
2009-05-14	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+4,335 sh	—	—	88,320
2009-04-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+4,281 sh	—	—	83,985
2009-01-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+3,226 sh	—	—	79,704
2008-01-31	CYGNE DESIGNS INCA Award	Director	AAward	+9,259 sh	—	—	50,394
2007-12-11	CYGNE DESIGNS INCA Award	Director	AAward	+10.5K sh	—	—	41,135
2007-10-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+4,726 sh	—	—	53,674
2007-06-18	CYGNE DESIGNS INCM Exercise/Conversion	Director	MExercise/Conversion	+500 sh	$0.13	+$65	30,650
2007-06-18	CYGNE DESIGNS INCOption to purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−500 sh	—	—	0
2006-05-12	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+1,772 sh	—	—	22,148
2006-01-17	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,356 sh	—	—	16,576
2005-07-28	NPS PHARMACEUTICALS INCS Sale	Director	SSale	−1,000 sh	$10.87	−$10.9K	0
2005-07-15	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+2,808 sh	—	—	10,870
2005-06-28	NPS PHARMACEUTICALS INCDeferred Stock UnitsA Award	Director	AAward	+8,062 sh	—	—	8,062
2005-05-23	NPS PHARMACEUTICALS INCS Sale	Director	SSale	−2,350 sh	$12.74	−$29.9K	1,000
2004-05-20	NPS PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+3,000 sh	$21.73	+$65.2K	3,000
2004-01-06	NPS PHARMACEUTICALS INCA Award	Director	AAward	+2,400 sh	$31.60	+$75.8K	23,698

Recent filings

Accepted (ET)
Feb 244
NPS PHARMACEUTICALS INC0001104659-15-013581
SEC(opens sec.gov)
Feb 204
NPS PHARMACEUTICALS INC0001104659-15-012647
SEC(opens sec.gov)
Feb 144
NPS PHARMACEUTICALS INC0000890465-14-000036
SEC(opens sec.gov)
Dec 264
NPS PHARMACEUTICALS INC0000890465-13-000037
SEC(opens sec.gov)
Aug 224
NPS PHARMACEUTICALS INC0000890465-13-000013
SEC(opens sec.gov)
Feb 154
NPS PHARMACEUTICALS INC0001474064-13-000040
SEC(opens sec.gov)
Feb 114
NPS PHARMACEUTICALS INC0001474064-13-000024
SEC(opens sec.gov)
Feb 94
NPS PHARMACEUTICALS INC0001474064-12-000023
SEC(opens sec.gov)

Companies

Address

550 HILLS DRIVE

BEDMINSTER, NJ, 07921